Health
Novel T-cell therapy shows promise to treat COVID-19 in high-risk patients – Healio
An off-the-shelf, virus-specific T-cell therapy demonstrated proof of concept to enter a clinical trial for the treatment of severe COVID-19 infection, according…
Source/Disclosures
Source: Vasileiou S, et al. Abstract 612. Presented at: ASH Annual Meeting and Exposition (virtual meeting); Dec. 5-8, 2020.
Disclosures:
Vasileiou reports a consultant role with and research funding from AlloVir. Please see the abstract for all other researchers’ relevant financial disclosures.
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected] to Healio
An off-the-shelf, virus-specific…
-
Noosa News15 hours ago‘Sunny, benign’ school holiday weather after morning showers in parts of Queensland
-
Noosa News12 hours agoTips to improve engagement – Proctor
-
Business16 hours agoWhy is Alphabet stock worth less than Nvidia, Microsoft, Apple, and Amazon even though it is the most profitable S&P 500 company?
-
General22 hours agoMichael Beatty, veteran current affairs journalist and animal welfare advocate, dies aged 76